Multiple chemical sensitivity syndrome and porphyria: A note of caution and concern

Archives of Internal Medicine

Volumn 157, Issue 3, 1997, Pages 281-285

  Hahn, Martin ^a   Bonkovsky, Herbert L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPROPORPHYRIN; COPROPORPHYRINOGEN OXIDASE;

ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MULTIPLE CHEMICAL SENSITIVITY; PATHOGENESIS; PATHOPHYSIOLOGY; PORPHYRIA; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; URINARY EXCRETION;

EID: 0031025432     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.3.281     Document Type: Article

References (35)

1. Randolph TG. Human Ecology and Susceptibility to the Chemical Environment Springfield, III: Charles C Thomas Publisher; 1962.
2. Terr AI. Environmental illness: a clinical review of 50 cases. Arch Intern Med. 1986;146:145-149.
3. Terr AI. Clinical ecology in the workplace. J Occup Med. 1989;31:257-261.
4. Terr AI. Immunological issues in multiple chemical sensitivities. Regul Toxicol Pharmacol. 1993; 18:54-60.
5. Wolf C. Multiple chemical sensitivities: is there a scientific basis? Int Arch Occup Environ Health. 1994;66:213-216.
6. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987;2: 655-661.
7. Sikorski EE, Kipen HM, Seiner JC, Miller CM, Rodgers KE. Roundtable summary: the question of multiple chemical sensitivity. Fund Appl Toxicol. 1995;24:22-28.
8. Donnay A, Ziem G. Chemical Injury and Disorders of Porphyrin Metabolism: Protocol for Diagnosing Disorders of Porphyrin Metabolism in Chemically Sensitive Patients. Baltimore, Md: MCS Referral and Resources; 1995.
9. Morton WE. Redefinition of abnormal susceptibility to environmental chemicals. Presented at the Second International Congress on Hazardous Waste: Impact on Human and Ecological Health; June 6, 1995; Atlanta, Ga.
10. Ashford NA, Miller CS. Chemical Exposures: Low Levels and High Stakes. New York, NY: Van Nostrand Reinhold Co; 1991:214.
11. Jewett DL. Diagnosis and treatment of hypersensitivity syndrome. Toxicol Ind Health. 1992; 8:111-123.
12. Rea WJ. Environmentally triggered small vessel vasculitis. Ann Allergy. 1977;38:245.
13. Bolla-Wilson K, Wilson RJ, Bleecker M. Conditioning of physical symptoms after neurotoxic exposure. J Occup Med. 1988;30:684-686.
14. Spyker DA. Multiple chemical sensitivies: syndrome and solution. J Toxicol Clin Toxicol. 1995; 33:95-99.
15. Meggs WJ. Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Environ Health Perspect. 1995;103:54-56.
16. Friedman MJ. Neurobiological sensitization models of post-traumatic stress disorder: their possible relevance to multiple chemical sensitivity syndrome. Toxicol Ind Health. 1994;10:449-462.
17. Shusterman D, Balmer J, Cone J. Behavioral sensitization to irritants/odorants after acute overexposure. J Occup Med. 1988;30:565-567.
18. Antelman SM, Kocan D, Knopf S, Edwards DJ, Caggiula AR. One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci. 1992;51:261-266.
19. Antelman SM. Time-dependent sensitization in animals: a possible model of multiple chemical sensitivity in humans. Toxicol Ind Health. 1994; 10:335-342.
20. Sorg BA, Hooks MS, Kalivas PW. Neuroanatomy and neurochemical mechanisms of time-dependent sensitization. Toxicol Ind Health. 1994; 10:369-386.
21. Bell IR, Miller CS, Schwartz GE. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry. 1992; 32:218-242.
22. Bell IR. White Paper: neuropsychiatric aspects of sensitivity to low-level chemicals: a neural sensitization model. Toxicol Ind Health. 1994;10: 277-312.
23. Environmental Studies and Toxicology Board, National Research Council. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: National Academic Press; 1992.
24. Council on Scientific Affairs, American Medical Association. Clinical ecology. JAMA. 1992;268: 3465-3467.
25. Bloomer JR, Bonkovsky HL. The porphyrias. Dis Mon. 1989;35:1-54.
26. Schmid R. Cutaneous porphyria in Turkey. N Engl J Med. 1960;263:397-398.
27. Cantoni L, Rizzardini M, Graziani A, Carugo C, Garattini S. Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase. Ann N Y Acad Sci. 1987;514:128-140.
28. Bernard A, Lauwerys R. Metal-induced alteration of δ-aminolevulinic acid dehydratase. Ann N Y Acad Sci. 1987;514:41-47.
29. Woods JS, Fowler BA. Metal alteration of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. Ann N Y Acad Sci. 1987;514: 55-64.
30. Woods JS, Fowler BA. Renal porphyrinuria during chronic methyl mercury exposure. J Lab Clin Med. 1977;90:266-272.
31. Fowler BA, Oskarsson A, Woods JS. Metal- and metalloid-induced porphyrinurias: relationships to cell injury. Ann N Y Acad Sci. 1987;514:172-182.
32. Bonkovsky HL. Porphyria: practical advice for the clinical gastroenterologist and hepatologist. Dig Dis. 1987;5:179-192.
33. Doss MO, Porphyrinurias and occupational disease. Ann N Y Acad Sci. 1987;514:204-218.
34. Grandchamp B, Nordmann Y. Decreased lymphocyte coproporphyrinogen III oxidase activity in hereditary coproporphyria. Biochem Biophys Res Commun. 1977;74:1089-1095.
35. Grandchamp B, Nordmann Y. Coproporphyrinogen III oxidase assay. Enzyme. 1982;28:196-205.